.25 dose of semaglutide Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) Wegovy Users More Likely to

Early evidence also suggests benefits in reducing liver fat and inflammation, which can help those with conditions like non-alcoholic fatty liver disease (NAFLD). What Are GLP-1 Supplements

Kao L, Hui KK, Hui E

All of this has stirred interest in the natural ingredients that mimic or support GLP-1 functions, without limitations

And thats my life. Michael Rubin Fanatics founder Michael Rubin revealed in July 2023 that he used Ozempic competitor Mounjaro to shed some unwanted pounds, otherwise hed be the Pillsbury Doughboy. He then joked that plastic surgery would be his next step toward eternal youth

Strength sessions feel more stable across sets